Ardent Health Partners (NYSE:ARDT) Rating Reiterated by Stephens

Ardent Health Partners (NYSE:ARDT)‘s stock had its “overweight” rating reaffirmed by equities researchers at Stephens in a note issued to investors on Thursday, Benzinga reports. They presently have a $24.00 target price on the stock. Stephens’ price target indicates a potential upside of 31.29% from the company’s previous close.

Several other equities research analysts have also recently weighed in on the company. Morgan Stanley assumed coverage on Ardent Health Partners in a research note on Monday, August 12th. They issued an “overweight” rating and a $27.00 price target on the stock. Mizuho assumed coverage on Ardent Health Partners in a research note on Monday, August 12th. They issued an “outperform” rating and a $20.00 price target on the stock. Royal Bank of Canada assumed coverage on Ardent Health Partners in a research note on Monday, August 12th. They issued an “outperform” rating and a $23.00 price target on the stock. Bank of America assumed coverage on Ardent Health Partners in a report on Monday, August 12th. They issued a “buy” rating and a $22.00 target price on the stock. Finally, Citigroup assumed coverage on Ardent Health Partners in a report on Monday, August 12th. They issued a “buy” rating and a $21.00 target price on the stock. One equities research analyst has rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of $21.70.

Ardent Health Partners Stock Performance

ARDT opened at $18.28 on Thursday. The company’s 50 day simple moving average is $17.60. Ardent Health Partners has a 52-week low of $15.00 and a 52-week high of $20.30.

Ardent Health Partners (NYSE:ARDT) last issued its quarterly earnings results on Wednesday, August 14th. The company reported $0.35 earnings per share for the quarter, topping the consensus estimate of $0.30 by $0.05. The firm had revenue of $1.47 billion during the quarter, compared to analysts’ expectations of $1.46 billion. As a group, equities analysts anticipate that Ardent Health Partners will post 1.25 EPS for the current year.

About Ardent Health Partners

We are the fourth largest privately held, for-profit operator of hospitals and a leading provider of healthcare services in the United States(1). We currently operate in eight growing mid-sized urban markets across six states: Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas. We deliver care through a system of 30 acute care hospitals, more than 200 sites of care, and over 1,700 providers that are either employed by or affiliated with us(2), as of March 31, 2024.